Russia publishes misleading information to make Americans question whether US has rushed to approve Pfizer vaccine from COVID-19, informs businessinsider.com.
“We can say that those news portals are directly related to Russia’s intelligence services,” an official from the State Department’s Global Engagement Center told the newspaper. – They are registered outside the United States and owned by foreign companies. The coverage, tone and audience of the portals vary widely, but they are all part of Russia’s propaganda and disinformation ecosystem. “
In November, Russian President Vladimir Putin said the country hoped to distribute the controversial Sputnik V coronavirus vaccine to other countries. Russia announced the success of the vaccine back in August, but the circumstances surrounding the approval of Sputnik V are in doubt. The vaccine was introduced without a third phase of studies. In the US, this step is necessary for the drug or vaccine to be evaluated and approved by the Food and Drug Administration.
Urgent action has led officials to speculate as to whether the Kremlin was pressuring vaccine developers to quickly complete Sputnik V in order to gain an advantage in the global race to vaccinate against the new coronavirus.
U.S. intelligence officials now believe the Kremlin’s efforts to downplay the vaccine developed by Pfizer are another way. “Sputnik VTo strengthen its status, writes the Wall Street Journal.
Johnson & Johnson is the latest company to enter the COVID-19 vaccine. The health care giant is offering a single-dose vaccine, which it hopes will soon vaccinate 4 million. american.
The vaccine, developed by Johnson & Johnson, was approved by the Food and Drug Administration in late February. Representatives of the company said they expect to vaccinate 20 million by the end of March. people, by the end of June – 100 million.
The U.S. population is now vaccinated with three effective vaccines, including the Johnson & Johnson variant.
Pfizer and Moderna, two companies that previously developed coronavirus vaccines after Johnson & Johnson, account for 94 percent of the total. and 95 percent. effectiveness.
–
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any form without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.
